| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |